BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Izbicki JR, Hosch SB, Pichlmeier U, Rehders A, Busch C, Niendorf A, Passlick B, Broelsch CE, Pantel K. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med. 1997;337:1188-1194. [PMID: 9337377 DOI: 10.1056/nejm199710233371702] [Cited by in Crossref: 266] [Cited by in F6Publishing: 52] [Article Influence: 11.1] [Reference Citation Analysis]
Number Citing Articles
1 Yekebas EF, Bogoevski D, Bubenheim M, Link BC, Kaifi JT, Wachowiak R, Mann O, Kutup A, Cataldegirmen G, Wolfram L, Erbersdobler A, Klein C, Pantel K, Izbicki JR. Strong prognostic value of nodal and bone marrow micro-involvement in patients with pancreatic ductal carcinoma receiving no adjuvant chemotherapy. World J Gastroenterol 2006;12:6515-21. [PMID: 17072983 DOI: 10.3748/wjg.v12.i40.6515] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
2 Tao L, Lefèvre M, Ricci S, Saintigny P, Callard P, Périé S, Lacave R, Bernaudin JF, Lacau St Guily J. Detection of occult carcinomatous diffusion in lymph nodes from head and neck squamous cell carcinoma using real-time RT-PCR detection of cytokeratin 19 mRNA. Br J Cancer 2006;94:1164-9. [PMID: 16622440 DOI: 10.1038/sj.bjc.6603073] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
3 Chen SB, Liu DT, Huang SJ, Weng HR, Wang G, Li H, Chen YP. Prognostic value of occult lymph node metastases in patients with completely resected esophageal squamous cell carcinoma. Sci Rep 2020;10:22007. [PMID: 33319855 DOI: 10.1038/s41598-020-79073-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hosch SB, Stoecklein NH, Izbicki JR. Molecular markers and staging of early esophageal cancer. Langenbecks Arch Surg 2003;388:77-82. [PMID: 12712339 DOI: 10.1007/s00423-003-0353-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
5 Carder C, Fielding P, Roberts A, Foley K. Discordant nodal staging identifies intermediate-risk group for overall survival in patients with cT3 oesophageal adenocarcinoma. Eur Radiol 2020;30:3429-37. [PMID: 32055952 DOI: 10.1007/s00330-019-06642-6] [Reference Citation Analysis]
6 Marjanovic G, Schricker M, Walch A, zur Hausen A, Hopt UT, Imdahl A, Makowiec F. Detection of lymph node involvement by cytokeratin immunohistochemistry is an independent prognostic factor after curative resection of esophageal cancer. J Gastrointest Surg. 2011;15:29-37. [PMID: 20976569 DOI: 10.1007/s11605-010-1359-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
7 Milsmann C, Füzesi L, Werner C, Becker H, Horstmann O. [Significance of occult lymphatic tumor spread in pancreatic cancer]. Chirurg. 2005;76:1064-1072. [PMID: 15971035 DOI: 10.1007/s00104-005-1041-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
8 Rauser S, Langer R, Tschernitz S, Gais P, Jütting U, Feith M, Höfler H, Walch A. High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma. BMC Cancer 2010;10:608. [PMID: 21054833 DOI: 10.1186/1471-2407-10-608] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
9 Schlick CJR, Khorfan R, Odell DD, Merkow RP, Bentrem DJ. Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach? Ann Surg Oncol 2020;27:4443-56. [PMID: 32519142 DOI: 10.1245/s10434-020-08578-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Sheyhidin I, Nabi G, Hasim A, Zhang RP, Ainiwaer J, Ma H, Wang H. Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma. World J Gastroenterol 2011;17:3745-51. [PMID: 21990957 DOI: 10.3748/wjg.v17.i32.3745] [Cited by in CrossRef: 67] [Cited by in F6Publishing: 61] [Article Influence: 7.4] [Reference Citation Analysis]
11 Friederichs J, Gertler R, Rosenberg R, Nahrig J, Führer K, Holzmann B, Dittler HJ, Dahm M, Thorban S, Nekarda H. Prognostic impact of CK-20-positive cells in peripheral venous blood of patients with gastrointestinal carcinoma. World J Surg. 2005;29:422-428. [PMID: 15770378 DOI: 10.1007/s00268-004-7662-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
12 Saito H, Sato T, Miyazaki M. Extramural lymphatic drainage from the thoracic esophagus based on minute cadaveric dissections: fundamentals for the sentinel node navigation surgery for the thoracic esophageal cancers. Surg Radiol Anat 2007;29:531-42. [PMID: 17710360 DOI: 10.1007/s00276-007-0257-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
13 Bézu C, Coutant C, Ballester M, Feron JG, Rouzier R, Uzan S, Daraï E. Ultrastaging of lymph node in uterine cancers. J Exp Clin Cancer Res 2010;29:5. [PMID: 20092644 DOI: 10.1186/1756-9966-29-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
14 Taniguchi K, Iida T, Hori T, Yagi S, Imai H, Shiraishi T, Uemoto S. Impact of lymph node micrometastasis in hilar bile duct carcinoma patients. World J Gastroenterol. 2006;12:2549-2555. [PMID: 16688800 DOI: 10.3748/wjg.v12.i16.2549] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
15 Schumacher S, Bartenhagen C, Hoffmann M, Will D, Fischer JC, Baldus SE, Vay C, Fluegen G, Dizdar L, Vallböhmer D, Klein CA, Knoefel WT, Stoecklein NH, Möhlendick B. Disseminated tumour cells with highly aberrant genomes are linked to poor prognosis in operable oesophageal adenocarcinoma. Br J Cancer 2017;117:725-33. [PMID: 28728164 DOI: 10.1038/bjc.2017.233] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
16 Bogoevski D, Strate T, Yekebas EF, Izbicki JR. Pancreatic cancer: a generalized disease--prognostic impact of cancer cell dissemination. Langenbecks Arch Surg 2008;393:911-7. [PMID: 18202848 DOI: 10.1007/s00423-007-0278-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
17 Bonavina L, Ferrero S, Midolo V, Buffa R, Cesana B, Peracchia A. Lymph node micrometastases in patients with adenocarcinoma of the esophagogastric junction. J Gastrointest Surg 1999;3:468-76. [PMID: 10482702 DOI: 10.1016/s1091-255x(99)80099-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
18 Neuhaus P, Jonas S, Settmacher U, Thelen A, Benckert C, Lopez-Hänninen E, Hintze RE. Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality. Langenbecks Arch Surg. 2003;388:194-200. [PMID: 12819970 DOI: 10.1007/s00423-003-0383-5] [Cited by in Crossref: 117] [Cited by in F6Publishing: 100] [Article Influence: 6.5] [Reference Citation Analysis]
19 Collard JM, Otte JB, Fiasse R, Laterre PF, De Kock M, Longueville J, Glineur D, Romagnoli R, Reynaert M, Kestens PJ. Skeletonizing en bloc esophagectomy for cancer. Ann Surg 2001;234:25-32. [PMID: 11420480 DOI: 10.1097/00000658-200107000-00005] [Cited by in Crossref: 76] [Cited by in F6Publishing: 62] [Article Influence: 3.8] [Reference Citation Analysis]
20 Griffiths EA, Pritchard SA, Mapstone NP, Welch IM. Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology - an update for the surgical oncologist. World J Surg Oncol. 2006;4:82. [PMID: 17118194 DOI: 10.1186/1477-7819-4-82] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
21 Pantel K, Alix-panabières C, Riethdorf S. Cancer micrometastases. Nat Rev Clin Oncol 2009;6:339-51. [DOI: 10.1038/nrclinonc.2009.44] [Cited by in Crossref: 459] [Cited by in F6Publishing: 402] [Article Influence: 38.3] [Reference Citation Analysis]
22 Kano M, Shimada Y, Kaganoi J, Sakurai T, Li Z, Sato F, Watanabe G, Imamura M. Detection of lymph node metastasis of oesophageal cancer by RT-nested PCR for SCC antigen gene mRNA. Br J Cancer 2000;82:429-35. [PMID: 10646900 DOI: 10.1054/bjoc.1999.0938] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
23 Hata M, Machi J, Mamou J, Yanagihara ET, Saegusa-Beecroft E, Kobayashi GK, Wong CC, Fung C, Feleppa EJ, Sakamoto K. Entire-volume serial histological examination for detection of micrometastases in lymph nodes of colorectal cancers. Pathol Oncol Res 2011;17:835-41. [PMID: 21494849 DOI: 10.1007/s12253-011-9390-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
24 Bogoevski D, Chayeb H, Cataldegirmen G, Schurr PG, Kaifi JT, Mann O, Yekebas EF, Izbicki JR. Nodal microinvolvement in patients with carcinoma of the papilla of vater receiving no adjuvant chemotherapy. J Gastrointest Surg 2008;12:1830-7; discussion 1837-8. [PMID: 18791769 DOI: 10.1007/s11605-008-0683-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
25 Schewe DM, Aguirre-Ghiso JA. ATF6alpha-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo. Proc Natl Acad Sci USA. 2008;105:10519-10524. [PMID: 18650380 DOI: 10.1073/pnas.0800939105] [Cited by in Crossref: 211] [Cited by in F6Publishing: 197] [Article Influence: 16.2] [Reference Citation Analysis]
26 Valcourt JR, Lemons JM, Haley EM, Kojima M, Demuren OO, Coller HA. Staying alive: metabolic adaptations to quiescence. Cell Cycle 2012;11:1680-96. [PMID: 22510571 DOI: 10.4161/cc.19879] [Cited by in Crossref: 132] [Cited by in F6Publishing: 114] [Article Influence: 14.7] [Reference Citation Analysis]
27 Saeed NA, Mellon EA, Meredith KL, Hoffe SE, Shridhar R, Frakes J, Fontaine JP, Pimiento JM, Kothari N, Almhanna K. Adjuvant chemotherapy and outcomes in esophageal carcinoma. J Gastrointest Oncol 2017;8:816-24. [PMID: 29184685 DOI: 10.21037/jgo.2017.07.10] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
28 Offner S, Schmaus W, Witter K, Baretton GB, Schlimok G, Passlick B, Riethmüller G, Pantel K. p53 gene mutations are not required for early dissemination of cancer cells. Proc Natl Acad Sci U S A 1999;96:6942-6. [PMID: 10359818 DOI: 10.1073/pnas.96.12.6942] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 1.7] [Reference Citation Analysis]
29 MacGuill MJ, Barrett C, Ravi N, MacDonald G, Reynolds JV. Isolated tumour cells in pathological node-negative lymph nodes adversely affect prognosis in cancer of the oesophagus or oesophagogastric junction. J Clin Pathol 2007;60:1108-11. [PMID: 17220206 DOI: 10.1136/jcp.2006.044149] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
30 Tabira Y, Yasunaga M, Sakaguchi T, Yamaguchi Y, Okuma T, Kawasuji M. Outcome of histologically node-negative esophageal squamous cell carcinoma. World J Surg 2002;26:1446-51. [PMID: 12297913 DOI: 10.1007/s00268-002-6415-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
31 Li M, Zhang X, Zhao F, Luo Y, Kong L, Yu J. Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice. Radiat Oncol 2016;11:18. [PMID: 26846932 DOI: 10.1186/s13014-016-0589-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
32 Tojima Y, Nagino M, Ebata T, Uesaka K, Kamiya J, Nimura Y. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma. Ann Surg. 2003;237:201-207. [PMID: 12560778 DOI: 10.1097/01.sla.0000048446.18118.fc] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
33 Wang Y, Zhang X, Zhang X, Liu-Helmersson J, Zhang L, Xiao W, Jiang Y, Liu K, Sang S. Prognostic value of the extent of lymphadenectomy for esophageal cancer-specific survival among T1 patients. BMC Cancer 2021;21:403. [PMID: 33853577 DOI: 10.1186/s12885-021-08080-4] [Reference Citation Analysis]
34 Balalis GL, Thompson SK. Sentinel lymph node biopsy in esophageal cancer: an essential step towards individualized care. Ann Surg Innov Res. 2014;8:2. [PMID: 24829610 DOI: 10.1186/1750-1164-8-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
35 Thorban S, Rosenberg R, Busch R, Roder RJ. Epithelial cells in bone marrow of oesophageal cancer patients: a significant prognostic factor in multivariate analysis. Br J Cancer 2000;83:35-9. [PMID: 10883665 DOI: 10.1054/bjoc.2000.1199] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
36 Xu HT, Miao J, Liu JW, Zhang LG, Zhang QG. Prognostic value of circulating tumor cells in esophageal cancer. World J Gastroenterol 2017;23:1310-8. [PMID: 28275311 DOI: 10.3748/wjg.v23.i7.1310] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
37 Hiraki Y, Kimura Y, Imano M, Kato H, Iwama M, Shiraishi O, Yasuda A, Shinkai M, Makino T, Motoori M, Yamasaki M, Miyata H, Satou T, Satoh T, Furukawa H, Yano M, Doki Y, Yasuda T. Controlling lymph node micrometastases by neoadjuvant chemotherapy affects the prognosis in advanced esophageal squamous cell carcinoma. Surg Today 2021;51:118-26. [PMID: 32596796 DOI: 10.1007/s00595-020-02059-7] [Reference Citation Analysis]
38 Fukagawa T, Sasako M, Ito S, Nakanishi H, Iinuma H, Natsugoe S, Katai H, Shimoda T. The prognostic significance of isolated tumor cells in the lymph nodes of gastric cancer patients. Gastric Cancer 2010;13:191-6. [PMID: 20820989 DOI: 10.1007/s10120-010-0556-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
39 Yu W, Chu L, Zhao K, Chen H, Xiang J, Zhang Y, Li H, Zhao W, Sun M, Wei Q, Fu X, Xie C, Zhu Z. A nomogram based on phosphorylated AKT1 for predicting locoregional recurrence in patients with oesophageal squamous cell carcinoma. J Cancer 2017;8:3755-63. [PMID: 29151963 DOI: 10.7150/jca.20828] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
40 He X, Xu X, Zhu G, Ye H. Circulating uPA as a potential prognostic biomarker for resectable esophageal squamous cell carcinoma. Medicine (Baltimore) 2019;98:e14717. [PMID: 30817615 DOI: 10.1097/MD.0000000000014717] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
41 Allgayer H, Aguirre-Ghiso JA. The urokinase receptor (u-PAR)--a link between tumor cell dormancy and minimal residual disease in bone marrow? APMIS 2008;116:602-14. [PMID: 18834405 DOI: 10.1111/j.1600-0463.2008.00997.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
42 Thompson SK, Bartholomeusz D, Devitt PG, Lamb PJ, Ruszkiewicz AR, Jamieson GG. Feasibility study of sentinel lymph node biopsy in esophageal cancer with conservative lymphadenectomy. Surg Endosc 2011;25:817-25. [PMID: 20725748 DOI: 10.1007/s00464-010-1265-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
43 Xu C, Liu Y, Huang J, Wang H, Tan L, Xu Y, Jiang Z, Wang X, Hou Y, Jiang D, Wang Q. The prognostic significance of MCL1 copy number gain in esophageal squamous cell carcinoma. Oncotarget 2017;8:87699-709. [PMID: 29152113 DOI: 10.18632/oncotarget.21181] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
44 Scheunemann P, Stoecklein NH, Rehders A, Bidde M, Metz S, Peiper M, Eisenberger C, Schulte Am Esch J, Knoefel WT, Hosch SB. Frequency and prognostic significance of occult tumor cells in lymph nodes in patients with adenocarcinoma of the papilla of Vater. HPB (Oxford) 2007;9:135-9. [PMID: 18333129 DOI: 10.1080/13651820601090646] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
45 Gómez-Hidalgo NR, Ramirez PT, Ngo B, Pérez-Hoyos S, Coreas N, Sanchez-Iglesias JL, Cabrera S, Franco S, Benavente AP, Gil-Moreno A. Oncologic impact of micrometastases or isolated tumor cells in sentinel lymph nodes of patients with endometrial cancer: a meta-analysis. Clin Transl Oncol 2020;22:1272-9. [PMID: 31863354 DOI: 10.1007/s12094-019-02249-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
46 Karstens KF, Ghadban T, Effenberger K, Sauter G, Pantel K, Izbicki JR, Vashist Y, König A, Reeh M. Lymph Node and Bone Marrow Micrometastases Define the Prognosis of Patients with pN0 Esophageal Cancer. Cancers (Basel) 2020;12:E588. [PMID: 32143307 DOI: 10.3390/cancers12030588] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Shang QX, Yang YS, Hu WP, Yuan Y, Ji AF, Chen LQ. Prognostic significance and role of thoracic lymph node metastasis based on Chinese expert consensus in esophageal cancer. Ann Transl Med 2019;7:381. [PMID: 31555695 DOI: 10.21037/atm.2019.07.63] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
48 Andasari V, Gerisch A, Lolas G, South AP, Chaplain MA. Mathematical modeling of cancer cell invasion of tissue: biological insight from mathematical analysis and computational simulation. J Math Biol 2011;63:141-71. [PMID: 20872264 DOI: 10.1007/s00285-010-0369-1] [Cited by in Crossref: 94] [Cited by in F6Publishing: 49] [Article Influence: 8.5] [Reference Citation Analysis]
49 Sasaki E, Nagino M, Ebata T, Oda K, Arai T, Nishio H, Nimura Y. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with gallbladder carcinoma. Ann Surg. 2006;244:99-105. [PMID: 16794394 DOI: 10.1097/01.sla.0000217675.22495.6f] [Cited by in Crossref: 51] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
50 Woestemeier A, Harms-Effenberger K, Karstens KF, Konczalla L, Ghadban T, Uzunoglu FG, Izbicki JR, Bockhorn M, Pantel K, Reeh M. Clinical Relevance of Circulating Tumor Cells in Esophageal Cancer Detected by a Combined MACS Enrichment Method. Cancers (Basel) 2020;12:E718. [PMID: 32197486 DOI: 10.3390/cancers12030718] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
51 Bogoevski D, Yekebas EF, Schurr P, Kaifi JT, Kutup A, Erbersdobler A, Pantel K, Izbicki JR. Mode of spread in the early phase of lymphatic metastasis in pancreatic ductal adenocarcinoma: prognostic significance of nodal microinvolvement. Ann Surg. 2004;240:993-1000; discussion 1000-1001. [PMID: 15570205 DOI: 10.1097/01.sla.0000145922.25106.e3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
52 Xi L, Coello MC, Litle VR, Raja S, Gooding WE, Yousem SA, El-Hefnawy T, Landreneau RJ, Luketich JD, Godfrey TE. A combination of molecular markers accurately detects lymph node metastasis in non-small cell lung cancer patients. Clin Cancer Res 2006;12:2484-91. [PMID: 16638856 DOI: 10.1158/1078-0432.CCR-05-2037] [Cited by in Crossref: 31] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]